Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on Addus HomeCare (NASDAQ:ADUS), maintaining a price target of $118.
August 04, 2023 | 11:03 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has reiterated an Outperform rating on Addus HomeCare, maintaining a price target of $118.
The reiteration of an Outperform rating by Oppenheimer indicates a positive outlook for Addus HomeCare. The maintained price target of $118 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100